ARTICLE | Company News
Neurocrine, Paladin deal
January 4, 2000 8:00 AM UTC
Paladin acquired exclusive worldwide rights to NBIX's neurosteroid program and acquired NBIX's Canadian affiliate, Neuroscience Pharma Inc. (Montreal, Quebec). NBIX will receive $2 million plus royal...